The coin toss of B cells in rejection and tolerance: Danger versus defense

Seminars in Immunology

Volumn 24, Issue 2, 2012, Pages 86-91

  Zarkhin, Valeriya ^a   Sarwal, Minnie M ^b  

^a STANFORD UNIVERSITY   (United States)

^b SUTTER HEALTH   (United States)

Author keywords

B cells; Microarray; Rejection; Tolerance; Transplantation

Indexed keywords

DACLIZUMAB; NANOPARTICLE; RITUXIMAB;

ALLOGRAFT; B LYMPHOCYTE; CELL LINEAGE; GRAFT REJECTION; HIGH THROUGHPUT SEQUENCING; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; METABOLOMICS; MICROARRAY ANALYSIS; NONHUMAN; ORGAN INJURY; ORGAN TRANSPLANTATION; PROTEOMICS; REVIEW; RISK ASSESSMENT; SAFETY; SURGICAL TECHNIQUE; TRANSPLANTATION TOLERANCE;

ANIMALS; B-LYMPHOCYTES; GRAFT REJECTION; HUMANS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 84859266415     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.09.003     Document Type: Review

References (68)

1. Merrill J.P., Murray J.E., Harrison J.H., Guild W.R. Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc 1956, 160(4):277-282.
2. Lechler R.I., Skykes M., Thomison A.W., Turka L.A. Organ transplantation-how much of the promise has been realized?. Nat Med 2005, 11(6):605-613.
3. Naesens M. Molecular diagnostics in transplantation. Nat Rev Nephrol 2010, 6(10):614-628.
4. Sarwal M., Chua M.S., Kambham N., Hsieh S.C., Satterwhite T., Masek M., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349(2):125-138.
5. Li L., Wadia P., Chen R., Kambham N., Naesens M., Sigdel T.K., et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and antibodyome measures. Proc Natl Acad Sci USA 2009, 106(11):4148-4153.
6. Li L., Sigdel T., Vitalone M., Lee S.H., Sarwal M. Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation. J Proteome Res 2010, 9(12):6715-6721.
7. Li L., Chen A., Chaudhuri A., Kambham N., Sigdel T., Chen R., et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010, 89(3):312-319.
8. Naesens M, Khatri P, Li L, Sigdel T, Vitalone M, Chen R, et al., Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int 2011; doi:10.1038/ki.2011.245.
9. Zarkhin V., Kambham N., Li L., Kwok S., Hsieh S.C., Salvatierra O., et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008, 74(5):664-673.
10. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007, 104(39):15448-15453.
11. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Hourcier K., Suthanthiran M., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120(6):1836-1847.
12. Zarkhin V., Li L., Sarwal M. To B or not to B? B-cells and graft rejection. Transplantation 2008, 85(12):1705-1714.
13. Zarkhin V., Chalasani G., Sarwal M.M. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) 2010, 24(2):67-78.
14. Luan F.L., Trillsch F., Henger A., Eichinger F., Norman S., Appelman H., et al. A pilot study of gene expression-based categorization of pancreas transplant biopsies. Transplantation 2009, 87(2):222-226.
15. Li L., Ying L., Naesens M., Xiao W., Sigdel T., Hsieh S., et al. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol Genomics 2008, 32(2):190-197.
16. Ying L., Sarwal M. In praise of arrays. Pediatr Nephrol 2009, 24(9):1643-1659.
17. Akalin E., O'Connell P.J. Genomics of chronic allograft injury. Kidney Int Suppl 2010, 78(119):S33-S37.
18. Sigdel T.K., Lee S., Sarwal M.M. Profiling the proteome in renal transplantation. Proteomics Clin Appl 2011, 5(5-6):269-280.
19. Sarwal M.M., Benjamin J., Butte A.J., Davis M.M., Wood K., Chapman J. Transplantomics and biomarkers in organ transplantation: a report from the first international conference. Transplantation 2011, 91(4):379-382.
20. Cadeiras M., Burke E., Dedrick R., Gangadin A., Latif F., Shahzad K., et al. Gene expression profiles of patients with antibody-mediated rejection after cardiac transplantation. J Heart Lung Transplant 2008, 27(8):932-934.
21. Zarkhin V., Lovelace P.A., Li L., Hsieh S.C., Sarwal M.M. Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients. Transplantation 2011, 91(9):1010-1018.
22. Zarkhin V., Li L., Sarwal M.M. BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection. Transplantation 2009, 88(10):1229-1230.
23. Sarantopoulos S., Stevenson K.E., Kim H.T., Washel W.S., Bhulya N.S., Cutler C.S., et al. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. Blood 2011, 117(7):2275-2283.
24. Walsh R.C., Brailey P., Girnita A., Alloway R.R., Shields A.R., Wall G.E., et al. Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation 2011, 91(11):1218-1226.
25. Zarkhin V., Chalasani G., Sarwal M.M. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev 2010, 24(2):67-78.
26. Woodle E.S., Alloway R.R., Girnita A. Proteasome inhibitor treatment of antibody-mediated allograft rejection. Curr Opin Organ Transplant 2011, 16(4):434-438.
27. Wahrmann M., Haidinger M., Körmöczi G.F., Weichhart T., Säemann M.D., Geyeregger R., et al. Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates. Transplantation 2010, 89(11):1385-1390.
28. Waiser J., Budde K., Schütz M., Liefeldt L., Rudolph B., Schönemann C., et al. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection. Nephrol Dial Transplant 2011.
29. Hillmen P., Young N.S., Schubert J., Brodsky R.A., Socié G., Muus P., et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006, 355(12):1233-1243.
30. Locke J.E., Magro C.M., Singer A.L., Segev D.L., Haas M., Hillel A.T., et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant. 2009, 9(1):231-235.
31. Biglarnia A.R., Nilsson B., Nilsson T., von Zur-Mühlen B., Wagner M., Berne C., et al. Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation. Transplant Int 2011, 24(8):e61-e66.
32. Cancro M.P. Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol 2009, 9(9):657-661.
33. Sandel P.C., Monroe J.G. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 1999, 10(3):289-299.
34. Miller J.P., Stadanlick J.E., Cancro M.P. Space, selection, and surveillance: setting boundaries with BLyS. J Immunol 2006, 176(11):6405-6410.
35. Parsons R.F., Vivek K., Redfield R.R., Migone T.S., Cancro M.P., Naji A., et al. B-cell tolerance in transplantation: is repertoire remodeling the answer?. Expert Rev Clin Immunol 2009, 5(6):703.
36. Parsons R.F., Vivek K., Rostami S.Y., Zekavat G., Ziaie S.M., Luo Y., et al. Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes. J Immunol 2011, 186(1):614-620.
37. Thaunat O., et al. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 2008, 85(11):1648-1653.
38. Thaunat O., Graff-Dubois S., Brouard S., Gautreau C., Varthaman A., Fabien N., et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS One 2010, 5(6):e11398.
39. Brown K., Sacks S.H., Wong W. Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. Eur J Immunol 2011, 41(1):89-96.
40. Le Texier L., et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011, 11(3):429-438.
41. Kirk A.D., Turgeon N.A., Iwakoshi N.N. B cells and transplantation tolerance. Nat Rev Nephrol 2010, 6(10):584-593.
42. Fan X., Ang A., Pollock-Barziv S.M., Dipchand A.I., Ruiz P., Wilson G., et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004, 10(11):1227-1233.
43. Sonnenday C.J., Warren D.S., Cooper M., Samaniego M., Haas M., King K.E., et al. Plasmapheresis: CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004, 4(8):1315-1322.
44. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., Fehrman I. ABO incompatible kidney transplantations without splenectomy: using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005, 5(1):145-148.
45. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., Fehrman I. ABO-incompatible kidney transplantation and rituximab. Transplant Proc 2005, 37(8):3286-3287.
46. Gugenheim J., Samuel D., Reynes M., Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990, 336(8714):519-523.
47. Stegall M.D., Dean P.G., Gloor J.M. ABO-incompatible kidney transplantation. Transplantation 2004, 78(5):635-640.
48. Sarwal M.M., Cecka J.M., Millan M.T., Salvatierra O. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing. Transplantation 2000, 70(12):1728-1736.
49. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 2011, 208(1):67-80.
50. Ierino F.L., Gojo S., Banerjee P.T., Giovino M., Xu Y., Gere J., et al. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation 1999, 67(8):1119-1128.
51. Fudaba Y., Spitzer T.R., Shaffer J., Kawai T., Fehr T., Delmonico F., et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006, 6(9):2121-2133.
52. Scandling J.D., Busque S., Dejbakhsh-Jones S., Benike C., Millan M.T., Shizuru J.A., et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008, 358(4):362-368.
53. Strober S., Dhillon M., Schubert M., Holm B., Engleman E., Benike C., et al. Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med 1989, 321(1):28-33.
54. Kawai T., Cosimi A.B., Spitzer T.R., Tolkoff-Rubin N., Suthanthiran M., Saidman S.L., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008, 358(4):353-361.
55. Sagoo P., Perucha E., Sawitzki B., Tomiuk S., Stephens D.A., Miqueu P., et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010, 120(6):1848-1861.
56. Thaunat O., Morelon E., Defrance T. AmBvalent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood 2010, 116(4):515-521.
57. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3(10):944-950.
58. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16(2):219-230.
59. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197(4):489-501.
60. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28(5):639-650.
61. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118(10):3420-3430.
62. Haas K.M., Watanabe R., Matsushita T., Nakashima H., Ishiura N., Okochi H., et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 2010, 184(9):4789-4800.
63. Watanabe R., Ishiura N., Nakashima H., Kuwano Y., Okochi H., Tamaki K., et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010, 184(9):4801-4809.
64. Amu S., Saunders S.P., Kronenberg M., Mangan N.E., Atzberger A., Fallon P.G. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010, 125(5):1114e8-1124e8.
65. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008, 224:201-214.
66. Iwata Y., Matsushita T., Horikawa M., Dilillo D.J., Yanaba K., Venturi G.M., et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011, 117(2):530-541.
67. Blair P.A., Noreña L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32(1):129-140.
68. Clatworthy M.R., Watson C.J., Plotnek G., Bardsley V., Chaudhry A.N., Bradley J.A., et al. B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med 2009, 360(25):2683-2685.